Transporters in Cancer: Mapping Metabolic Dependencies for Therapeutic Insight

ALOMONE LABS NEWS

Solute Carrier (SLC) transporters control nutrient flux in cancerous tumors to support growth, stress adaptation, and therapy resistance.

In this review:

Key transporter families are described

Transporters’ roles in breast cancer are outlined

Small-molecule and antibody-based strategies in development of cancer therapies are highlighte

You’ll also find a detailed table, categorized by epitope and fluorophore conjugation, that you can use in your own research. For researchers working on these transporters, Alomone Labs offers a wide range of validated antibodies, such as Anti-GLUT1 Antibody (#AGT-021), Anti-ASCT2 (SLC1A5) Antibody (#ANT-082), and Anti-xCT/SLC7A11 (extracellular) Antibody (#ANT-111), to support studies on nutrient uptake and therapeutic targeting in cancer.

Discover more https://www.alomone.com/article/transporters-and-cancer

Per maggiori informazioni Contattaci